Gebruikersprofielen voor "Mooi, F.R. "

Frits R Mooi

Centre for Infectious Diseases Control, The Netherlands
Geverifieerd e-mailadres voor rivm.nl
Geciteerd door 16966

Pertussis resurgence: waning immunity and pathogen adaptation–two sides of the same coin

FR Mooi, NAT Van Der Maas… - Epidemiology & Infection, 2014 - cambridge.org
Pertussis or whooping cough has persisted and resurged in the face of vaccination and has
become one of the most prevalent vaccine-preventable diseases in Western countries. The …

Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen

FR Mooi - Infection, Genetics and Evolution, 2010 - Elsevier
Before childhood vaccination was introduced in the 1950s, pertussis or whooping cough
was a major cause of infant death worldwide. Widespread vaccination of children was …

The case for maternal vaccination against pertussis

FR Mooi, SC de Greeff - The Lancet Infectious Diseases, 2007 - thelancet.com
Despite high vaccine coverage, the incidence of pertussis is increasing in a number of
countries. Particularly alarming is the increase of pertussis in infants too young to be (fully) …

Molecular typing of methicillin-resistantStaphylococcus aureus on the basis of protein A gene polymorphism

HME Frenay, AE Bunschoten, LM Schouls… - European Journal of …, 1996 - Springer
The polymorphic X-region of the protein A gene (spa) was used for molecular typing of
methicillin-resistantStaphylococcus aureus (MRSA) strains. The X-region is characterized by a …

[HTML][HTML] Bordetella pertussis strains with increased toxin production associated with pertussis resurgence

FR Mooi, IHM Van Loo, M Van Gent, Q He… - Emerging infectious …, 2009 - ncbi.nlm.nih.gov
Before childhood vaccination was introduced in the 1940s, pertussis was a major cause of
infant death worldwide. Widespread vaccination of children succeeded in reducing illness …

Polymorphism in the Bordetella pertussisVirulence Factors P.69/Pertactin and Pertussis Toxin in The Netherlands: Temporal Trends and Evidence for Vaccine-Driven …

FR Mooi, H van Oirschot, K Heuvelman… - Infection and …, 1998 - Am Soc Microbiol
The Bordetella pertussis proteins P.69 (also designated pertactin) and pertussis toxin are
important virulence factors and have been shown to confer protective immunity in animals and …

Bordetella pertussis, the Causative Agent of Whooping Cough, Evolved from a Distinct, Human-Associated Lineage of B. bronchiseptica

DA Diavatopoulos, CA Cummings, LM Schouls… - PLoS …, 2005 - journals.plos.org
Bordetella pertussis, B. bronchiseptica, B. parapertussis hu , and B. parapertussis ov are
closely related respiratory pathogens that infect mammalian species. B. pertussis and B. …

Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?

FR Mooi, IH Van Loo, AJ King - Emerging infectious diseases, 2001 - ncbi.nlm.nih.gov
… Van der Zee A, Vernooij S, Peeters M, van Embden JDA, Mooi FR. Dynamics of the …
Van Loo IHM, van der Heide HGJ, Nagelkerke NJD, Verhoef J, Mooi FR. Temporal trends in …

Pertussis disease burden in the household: how to protect young infants

SC de Greeff, FR Mooi, A Westerhof… - Clinical infectious …, 2010 - academic.oup.com
Background. We conducted a population-based, nation-wide, prospective study to identify
who introduced pertussis into the household of infants aged ⩽6 months admitted to the …

Genesis of the novel epidemic Vibrio cholerae O139 strain: evidence for horizontal transfer of genes involved in polysaccharide synthesis.

EM Bik, AE Bunschoten, RD Gouw, FR Mooi - The EMBO journal, 1995 - embopress.org
Only Vibrio cholerae strains of serotype O1 are known to cause epidemics, while non‐O1
strains are associated with sporadic cases of cholera. It was therefore unexpected that the …